Company Profile
Updated: 17-SEP-09ARYx Therapeutics
Public Company, Headquarters Location
6300 Dumbarton Cir., Freemont, CA 94555-3644, United States
(510)585-2200, (510)585-2202 fax, http://www.aryx.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Drugs for cardiovascular and gastrointestinal diseases.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Research and Markets Adds Report: Procter & Gamble: Pipeline, Products, Performance and Potential
Manufacturing Close-Up; 12/11/2009; 687 words; ...on financials, agreements and corporate events. Companies mentioned: - Alexion Pharmaceuticals - ARYx - AstraZeneca - Chemokine Therapeutics - Cincinnati Children's Hospital Medical Centre - Curis - Genzyme. - Nastech Pharmacecutical - Novartis...
Research and Markets Adds Report: Procter & Gamble: Pipeline, Products, Performance and Potential.(Company overview)
Health & Beauty Close-Up; 12/9/2009; 1052 words; ...financials, agreements and corporate events. Companies Mentioned: - Alexion Pharmaceuticals Inc - ARYx - AstraZeneca - Chemokine Therapeutics Corp. - Cincinnati Children's Hospital Medical Centre - Curis Inc - Genzyme Corp. - Nastech Pharmacecutical...
Procter & Gamble: Pipeline, Products, Performance And Potential: The Health Care Division Contributed 17.5 Per Cent Of Total Sales In Fiscal 2008.
M2 Presswire; 12/2/2009; 1117 words; ...Infrastructure - Subsidiaries and joint ventures Companies Mentioned: - Alexion Pharmaceuticals Inc - ARYx - AstraZeneca - Chemokine Therapeutics Corporation - Cincinnati Children's Hospital Medical Centre - Curis Inc - Genzyme Corporation - Nastech...
Research and Markets: Procter & Gamble: Pipeline, Products, Performance And Potential: The Health Care Division Contributed 17.5 Per Cent Of Total Sales In Fiscal 2008.
Business Wire; 12/2/2009; 1079 words; ...Infrastructure * Subsidiaries and joint ventures Companies Mentioned: * Alexion Pharmaceuticals Inc * ARYx * AstraZeneca * Chemokine Therapeutics Corporation * Cincinnati Children's Hospital Medical Centre * Curis Inc * Genzyme Corporation * Nastech...
Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart Association.
Clinical Trials Week; 11/30/2009; 841 words; ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical...for atrial fibrillation (see also ARYx Therapeutics, Inc.). "The primary efficacy...Therapies, Therapy, Treatment, ARYx Therapeutics Inc. This article was prepared by...
Recent News Articles
- ARYx Therapeutics Reports Third Quarter 2009 Results.(Financial report)
Business Wire - November 12, 2009 - ARYx Therapeutics Aligns Operations to Development Activities.
Biotech Week - November 11, 2009 - ARYx Therapeutics Schedules Third Quarter 2009 Results Conference Call.
Business Wire - November 05, 2009 - ARYx Therapeutics Secures $35 Million Committed Equity Financing Facility.
Biotech Week - October 21, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning